And costs 5 billion USD per year to treat.
Lani might not be biotas biggest cash cow if there is success with the new anti - infectives.
Just heard these stats on the discovery channel - great potential in this pipline in an ever expanding steady/ non season/ non pandemic market. Just what a co like biota needs to steady the ship.
